The research team tracked snippets of DNA across stem cells to identify 150 suspect proteins.
According to a new study, published in the journal Biological Psychiatry, in mice, modifying levels of a compound known as kynurenic acid could effectively treat symptoms of schizophrenia. Kynurenic acid is a
According to a new study by researchers at King’s College London, people with first-episode schizophrenia are at an increased risk to develop type 2 diabetes. However, for those who experience long-term schizophrenia, they
A new investigational antipsychotic drug, ITI-007, entered its phase 3 study with some promising results. According to Medscape, the findings from an earlier large phase 2b trial proved that the investigative drug
Researchers are strengthening the association between patients suffering from schizophrenia and heavy usage of tobacco. Smoking tobacco is a real problem for schizophrenics and can drastically decrease life expectancy, said Stéphane Potvin, one